Institute of Molecular Biology and Medicine (IBMM) - Seminars |
10 décembre 201312h30 |
Benoît Vanhollebeke (ULB, IBMM, Belgium) Brain vascular development: lessons from zebrafish genetics |
6 décembre 201311h00 |
Ralph Kehlenbach (University in Göttingen, Germany) Regulation of nuclear transport by nucleoporins |
19 novembre 201312h30 |
Cédric Szpirer (Delphigenetics, Belgium) Technologies Staby® pour de hauts rendements de bioproductions et le développement d'anticorps |
4 octobre 201312h00 |
Dina Danso-Abeam (KUL,VIB Lab of Genetics of Autoimmunity, Belgium) Mechanistic analysis of genetic defects in cutaneous immune tolerance |
1er octobre 201312h00 |
Pr Pierre Sonveaux (UCL, Medical School IREC, Pole of Pharmacology, Belgium) Lactate in cancer: from waste glycolytic end-product to tumor growth-promoting agent |
20 septembre 201311h00 |
Pr Reynald Gillet (Université de Rennes 1, France) Quality control of protein synthesis under the eye of the electron microscope |
12 septembre 201313h30 |
Pr Olivier Debeir (Université Libre de Bruxelles, LISA, Belgium) Quel traitement pour quelle image |
11 septembre 201311h00 |
Dr Dan Lazar (Promega Corp, Madison, WI, USA) Cell based Assays from Promega |
3 septembre 201312h00 |
Stephanie Schulz, PhD (Stanford University School of Medicine, USA) Postnatal acquisition of endotoxin tolerance in intestinal epithelial cells |
28 août 201312h00 |
Dominique Weil (Université Pierre et Marie Curie, Paris, France) The enigma of P-bodies and related mRNP granules |
5 juillet 201312h00 |
Pierre Smeesters (The Royal Children's Hospital Melbourne, Australia) Toward a vaccine against group A streptococcus |
28 juin 201312h30 |
Pr Flavia Bazzoni, PhD (Università di Verona, Italy) MicroRNA in inflammation |
21 juin 201312h |
Arnaud Didierlaurent (GSK Biologicals, ) Lessons learnt from studies comparing GSK adjuvant systems |
20 juin 201312h30 |
Jean-Michel Oost (FaceJobb, ) FaceJobb, une plateforme d'e-recrutement |
13 juin 201312h |
Pedro Romero (Ludwig Center for Cancer Research, University of Lausanne, Switzerland) Optimizing Peptide-based Cancer Vaccines |
11 juin 201312h |
Anthony Rongvaux (Yale University, ) A-to-I RNA editing in breast cancer |
28 mai 201312h |
Vincent Detours (, ) A-to-I RNA editing in breast cancer |
21 mai 201312h |
Karen Willard-Gallo (, ) The nature and organization of CD4+ T cell subsets infiltrating human breast cancer |
15 mai 201311h |
Dr. Kristine Henningfeld, PhD (Univesity of Goettingen, London, UK) The role of Ptf1a dimeric and trimeric transcriptional complexes during Xenopus neurogenesis |
26 avril 201312h |
Perry J. Blackshear (NIH/NIEHS, Duke University School of Medicine, North Carolina, USA) RNA binding proteins in inflammation and placental physiology |
15 février 201313h |
BIOKE (Formation on flow cytometry, The nederlands) |
22 janvier 201312h |
Delphine SAUCE (Hôpital Pitié-Salpêtrière, INSERM UMRS 945, Paris, France) Impact of CMV infection on T-cellhomeostasis |
18 janvier 201311h |
Marcus FISLAGE (VUB, Department of Structural Biology, Brussels) Structural and functional characterization of the tRNA: m2G6 methyltransferase TrmN/Trm14 |
11 décembre 201211h |
Jean-Christophe Foffard (Hôpital Erasme, AIDS Reference Center, Brussels) Primary immune deficencies in adults: opportunities for clinical and fundamental reasearch interactions |
4 décembre 201212h |
Seppo MERI (Haartman Institute, Helsinki, Finland) Microbial evasion of the complement system |
29 novembre 201211h |
Susan Gottesman (National Institute of Health, Laboratory of Molecular Biology, Bethesda, USA) to be defined |
23 novembre 201211h |
Miguel Navarro (Instituto de Parasitologia y Biomedicina Lopez-Neyra, CSIC, , Granada, Spain) to be defined |
13 novembre 201212h |
Andreas Ludwig (Universitätsklinikum Aachen, Institute of Pharmacology and Toxicology, Aachen, Germany) The melalloproteinase ADAM17 as accelerator of acute lung inflammation |
9 novembre 201211h |
Kim De Keersmaecker (KUL, VIB Center for the Biology of Disease, Leuven) Nextgenerationsequencingrevealsnovel driver genes in T-cellleukemia |
6 novembre 201212h |
Kathy Jaworski, Isabelle Debock (ULB, Institut d'Immunologie Medicale, Charleroi) Study of neonatalfollicularhelper T cells |
30 octobre 201214h30 |
Jinyu ZHANG (ULB, Institut d'Immunologie Medicale, Charleroi) miR155 and T cellfunction |
26 octobre 201214h30 |
Jean-Marie VANDERWINDEN (ULB - IRIBHM, Bruxelles) Tissue clearing for one and two-photon excitation "deep" imaging in the gut wall |
24 octobre 201214h30 |
Benjamin MERTENS (ULB, Ecole Polytechnique, BEAMS Department, Bruxelles) L'Endoscopie 3D: défis et perspectives |
28 septembre 201211h |
Patrick LAURENT (MRC-LMB - Cell Biology, Cambridge - UK) How genes and neural circuits coordinate behaviour in C. elegans |
25 septembre 201212h |
Marie NGUYEN-de BERNON (Institut Pasteur, Paris - France) Monitoring red blood cell surface area loss and splenic entrapment by imaging flow cytometry |
19 septembre 201211h |
Philip GOULDER (University of Oxford - Department of Paediatrics, Oxford - UK) Contrasting immune control of HIV in paediatric and adult infection |
22 juin 201211h |
Dr. isabelle MIGEOTTE (Université Libre de Bruxelles - IRIBHM, Bruxelles) Collective migration and embryo morphogenesis |
8 juin 201211h |
DR. Thomas THEIL (Centre for Integrative Physiology - University of Edinburgh, Edinburgh - UK) Gli3 controls patterning and axon pathfinding during telencephalic development |
31 mai 201211h |
Dr. eveline PEETERS (Vrije Universiteit Brussel - Microbiologie, Bruxelles) Prokaryotic regulation of a eukaryotic-like transcription machinery in Sulfolobus |
17 avril 201212h |
Dr Julian R. Marchesi (School of Biosciences - Cardiff university, Cardiff - UK) Why should we care about what's going on in our gut? Integrating the microbiome into host biology |
13 mars 201211h |
Dr Apolinar MAYA-MENDOZA (The University of Manchester - Faculty of Life Sciences, Manchester - UK) The role of DNA damage response machinery in S phase progression |
28 février 201212h |
Dr Pierre J. COURTOY (UCL, University Medical School, Bruxelles) Apical endocytosis : machineries, developmental regulation, vital imaging and disease... |
24 février 201212h |
Dr Yosef GRUENBAUM (The Hebrew University Jerusalem - Department of Genetics, Jérusalem, Israël) Regulation of gene expression, aging and metabolism by the nuclear lamina |
14 février 201212h |
Dr Marten SMIDT (University of Amsterdam, Swammerdam Institute for Life Sciences, Pays-Bas) A Pitx3 mediated program of dopaminergic subset-specification |
1er février 201212h |
Prof. Jean-Marie SAINT-REMY (Professeur à la KUL et Fondateur de la société IMCYSE, Leuven) Antigen-specific immunosuppression using synthetic peptides |
24 janvier 201212h |
Dr Pierre LARRIEU (Ludwig Institute for Cancer Research Ltd, Bruxelles) Two potential pathways to modulate anti-tumor immunity |